Anti-Human VEGFA Recombinant Antibody(Aflibercept)

Product Information

Catalog Number	YR1643
Product Name	Anti-Human VEGFA Recombinant Antibody(Aflibercept)
Molecular Name	Aflibercept
Alias	Anti-VEGFA Recombinant Antibody, Research Grade Aflibercept
CAS Number	862111-32-8
Molecular Weight	150 kDa
Target	VEGFA[Homo sapiens]
Isotype	Human IgG1
Clonity	Monoclonal
Source	CHO Cells
Size	1mg, 5mg
Concentration	1mg/ml
Purity	>95% as determined by SDS-PAGE
Buffer	PBS, pH7.5
Background	Aflibercept, sold under the brand names Eylea and Zaltrap, is a medication used to treat wet macular degeneration and metastatic colorectal cancer. It was developed by Regeneron Pharmaceuticals and is approved in the United States and the European Union.
Storage	It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
Note	This product is for research use only.

Cat#	Product Name	Species	Host	Applications	Size	Price